Recently, it was reported that the combination of an ATR inhibitor and a Chk1 inhibitor induces cancer-specific cell death in breast cancer cells and osteosarcoma cells [33], but there is no report about its effect on endometrial cancer cells. Here, CHEK1 is linked to endometrial cancer.